• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. Pharmaceutical Industry

Pharmaceutical Industry

Page 83 of 100

Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health

Aftershocks Keep Coming After Former Pharma CEO’s Arrest

By Reuters
December 24, 2015
Inside Teva Pharmaceuticals Headquarters
Health

Celgene Settles U.S. Patent Litigation for Revlimid

By Reuters and Aaron Task
December 23, 2015
APTOPIX Shkreli Arrest
Finance

KaloBios Just Fired Martin Shkreli as CEO

By Laura Lorenzetti
December 21, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health

Martin Shkreli Says This Is the Real Reason He Was Arrested

By Michal Addady
December 21, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health

Martin Shkreli’s Twitter Account Hacked

By Reuters and Aaron Task
December 21, 2015
Martin Shkreli arrested
Health

Martin Shkreli’s Arrest Halts Leukemia Drug Trial

By Michal Addady
December 20, 2015
Martin Shkreli Says Securities Fraud Charges Are ‘Baseless’
Leadership

Martin Shkreli Says Securities Fraud Charges Are ‘Baseless’

By Reuters
December 20, 2015
Inside of a Gilead Sciences Lab
Finance

Isis Pharmaceuticals Changes Its Name After Terrorists Attack Stock Price

By Jen Wieczner
December 18, 2015
US-CRIME-JUSTICE-SHKRELI
Health

Turing Replaces Martin Shkreli with Interim CEO

By Laura Lorenzetti
December 18, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Leadership

Martin Shkreli’s 15 Minutes Are Up

By Geoff Colvin
December 18, 2015
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
Health

How Pharmacies Are Dealing with Daraprim After Martin Shkreli’s Arrest

By Reuters
December 18, 2015
BRITAIN-PHARMACEUTICAL-GSK
Health

Europe’s Pharma Sector Is Finishing 2015 With a Deal Flurry

By Geoffrey Smith
December 18, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance

The Year’s Best VC Deal Was for a Company You’ve Never Heard Of

By Dan Primack
December 17, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health

AstraZeneca Wants a Stake in This Biotech Firm for a Cancer Cure

By Reuters
December 17, 2015
Views Of A CVS Caremark Corp. Store Ahead Of Earns
Retail

CVS Slams Walgreens-Valeant Distribution Deal

By Phil Wahba
December 16, 2015

Most Popular

  • AI
    Meta's 28-year-old billionaire prodigy says the next Bill Gates will be a 13-year-old who is 'vibe coding' right now
    By Eva Roytburg
  • Economy
    Trump's social security chief says 'everything' is on the table and retirement is about to get a 'different set of...
    By Eleanor Pringle
  • Economy
    Ray Dalio says the world is running out of interest in buying U.S. debt—but America is unable to cut back its spending
    By Eleanor Pringle
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.